Similar initiatives funded by
the European Commission

Aligned to understand and manage the COVID-19 pandemic

In response to the COVID-19 pandemic, the European Commission has funded several cohort-based projects.
We at ENDVOC, will participate and engage with similar initiatives in regular joint meetings with the leaders
of these consortia to update and align each other’s activities.

ORCHESTRA
University of Verona, Italy

Summary: Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic. Cohorts include all ages, conditions, & ‘at risk’ populations.

  • Countries: 37 partners from 15 countries – Argentina, Belgium, Brazil, Congo, France, Gabon, Germany, India, Italy, Luxemburg, Netherlands, Romania, Slovakia, Spain, Venezuela.
  • Aims: To generate evidence to improve prevention and treatment of COVID-19 and future preparedness.
EuCARE
EuResist Network GEIE, Italy

Summary: Assessing the impact of VOC on healthcare workers, hospitalized patients, PASC (long covid in or out of hospital), schools & kindergartens.

  • Countries: 18 partners from 13 countries – Italy, Denmark, United Kingdom, Sweden, Israel, Lituania, Portugal, Georgia, Belgium, Kenya, Vietnam, Mexico, Russia
CoVICIS
Lausanne University Hospital, Switzerland

Summary: Study of VOC impact on risk and protective factors in different risk, gender and age groups in EU and Africa. a) Total 9 cohorts: targeted participant cohorts, general population cohorts, paediatric cohorts b) Genomic virological surveillance c) immunological surveillance d) data science / integration.

  • Countries: 14 partners from 7 countries – Switzerland, Italy, France, Germany, the Netherlands, Ethiopia, South Africa
  • Aims: To identify VOC through genomic sequencing & surveillance in different cohorts, to evaluate the impact of VOCs on vaccine induced humoral and cellular resposnses in different populations,identifying immune correlates of protection against VOC through development of algorithms predicting the impact of VOCs on the efficacy of vaccines, informing future vaccine strategy and next generation vaccines.
VERDI
University Padua/Penta

Summary: The impact of VOC on children and pregnant women will be assessed through analysis of medical records, cohort studies, home transmission studies and screening programs.

  • Countries: 22 partners from 14 countries – Belgium, Switzerland, Denmark, Greece, France, Haiti, Italy, Netherlands, Norway, Slovenia, Thailand, United-Kingdom, USA, South Africa.
unCoVer
Institute of Tropical Medicine Antwerp, Belgium

Summary:16 different databases (national registries, observational cohorts, hospital data and population screening) Unravelling data for rapid evidence based response to Covid-19.

  • Countries: 29 partners from 18 countries – Spain, Portugal, Belgium, Ireland, Romania, Italy, Croatia, Luxembourg, Slovakia, Greece, Norway, Bosnia, Turkey, United-Kingdom, South Korea, Colombia, Brazil, USA.
ReCoDID
UKHD Heidelberg Institute of Global Health, Germany

Summary: Reconciliation of Cohort Data for Infectious Diseases: Developing an equitable, accessible, and sustainable model for the storage, curation, and analyses of complex clinical-epidemiological and laboratory datasets.

  • Countries: 15 partners from 9 countries – Germany, Netherlands, France, Denmark, Canada, USA, Colombia, Nicaragua, Senegal.
  • Aims: Integrated human data repositories for infectious disease-related international cohorts to foster personalized medicine approaches to infectious disease research.
European COVID-19 Data Platform
EMBL-EBI, UK

Summary: The European COVID-19 Data Platform facilitates data sharing and analysis in order to accelerate coronavirus research.

  • Aims: To track and characterize VOC, disease severity, treatment, transmission (household and school settings), vaccine effectiveness and inform vaccine strategy).